Relay Therapeutics
Drug Discovery · Biotechnology

Relay Therapeutics revenue, results and funding

Relay Therapeutics filed revenue of $15.4M for 2025.

Data updated Nov 22, 2026 · Back to the company report
$15.4MRevenue, 2025
−$276.5MNet income, 2025

Results by year

YearRevenueNet incomeTotal assetsLANG_CR_S_M_TAX_EXPENSELANG_CR_S_M_CAPEXLANG_CR_S_M_SBCLANG_CR_S_M_RNDLANG_CR_S_M_OPERATING_INCOMELANG_CR_S_M_CASHLANG_CR_S_M_ACQUISITIONS
2025$15.4M−$276.5M$621.3M$0$410k$62.4M$261.4M−$302.7M$84M–
2024$10M−$337.7M$871.3M$0$2M$94.1M$319.1M−$372.5M$124.3M–
2023$25.5M−$342M$844M$0$4.1M$86M$330M−$373M$143.7M–
2022$1.4M−$290.5M$1.1B$0$9.1M$56.1M$246.4M−$299.3M$151.8M–
2021$3M−$363.9M$1B$0$3.5M$48.5M$172.7M−$364.7M$280.1M$25.3M
2020$82.7M−$52.4M$799.8M$0$1.9M$32M$99.9M−$55.8M$447.6M–
2019–−$75.3M$393.1M$0$8M$4.5M$70.3M−$84M$42M–
Sources: SEC

How to cite

Relay Therapeutics, Financials. Alion, Nov 22, 2026. https://alion.io/company/relaytx/financials

.json · .md · CC BY-SA 4.0